Ekso Bionics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $4,129 | $4,950 | $3,756 | $4,847 |
Gross Profit | 2,209 | 2,637 | 1,951 | 2,369 |
EBITDA | -1,586 | -1,945 | -2,966 | -2,473 |
EBIT | -1,993 | -2,342 | -3,372 | -3,148 |
Net Income | -2,072 | -2,416 | -3,429 | -3,214 |
Net Change In Cash | 4,129 | 4,950 | 3,756 | 4,847 |
Free Cash Flow | -2,285 | -2,670 | -3,474 | -1,627 |
Cash | 8,292 | 5,885 | 8,799 | 8,638 |
Basic Shares | 20,310 | 18,224 | 17,419 | 14,446 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $18,279 | $12,912 | $11,246 | $8,882 |
Gross Profit | 9,079 | 6,214 | 6,749 | 5,070 |
EBITDA | -13,198 | -14,037 | -9,090 | -15,066 |
EBIT | -14,896 | -14,924 | -9,651 | -15,686 |
Net Income | -15,198 | -14,604 | -8,432 | -16,954 |
Net Change In Cash | 18,279 | 12,912 | 11,246 | 8,882 |
Cost of Revenue | 1,949 | |||
Free Cash Flow | -12,211 | -14,882 | -11,215 | -8,755 |
Cash | 8,638 | 20,525 | 40,406 | 12,862 |
Basic Shares | 13,867 | 12,962 | 12,269 | 7,164 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.10 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.22 |
